CVS Health Corporation (0HRS.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 0HRS.L in your mock portfolio yet.
The valuation multiples (PE ~30x on EPS of 3.11) imply the market is pricing in meaningful earnings growth or a recovery from depressed earnings, which is not fully supported by the recent price decline. Without evidence of accelerating earnings or margin expansion, the current multiple looks demanding for a mature healthcare/retail name like CVS. Overall, fundamentals appear stable but not clearly strong enough yet to justify a premium valuation, resulting in a neutral stance.
Technically, CVS looks oversold in the short term but remains in a longer‑term uptrend relative to its 200‑day moving average. The RSI at 28.49 signals oversold conditions, which often precede at least a technical rebound. Trading well above the 200‑day moving average suggests the primary trend is still constructive despite the recent pullback.
Alternative data for CVS is broadly positive, with app downloads and hiring both trending higher, signaling ongoing customer engagement and operational expansion. Social media metrics show modest but generally positive follower growth across most platforms, indicating stable to improving brand reach. These signals collectively point to healthy underlying demand and investment in growth, which can be supportive for the stock over the medium term.
Overall, CVS presents a mixed picture: technically oversold within a longer‑term uptrend and supported by positive alternative data, but trading at a relatively rich earnings multiple given recent price pressure. The balance of signals suggests a neutral stance: there is potential for a technical rebound and operational growth, but valuation and recent drawdown temper a clearly bullish view. Investors may see an opportunity on pullbacks, yet should remain mindful of execution and earnings‑growth risks.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started